INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Institutua
Instituto de Investigación Sanitaria La Fe
Valencia, EspañaInstituto de Investigación Sanitaria La Fe-ko ikertzaileekin lankidetzan egindako argitalpenak (15)
2023
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies
Scientific Reports, Vol. 11, Núm. 1
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Comprehensive functional characterization and clinical interpretation of 20 splice-site variants of the rad51c gene
Cancers, Vol. 12, Núm. 12, pp. 1-21
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
-
Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia
Breast cancer research : BCR, Vol. 22, Núm. 1, pp. 108
2019
-
Challenges to drug discovery for celiac disease and approaches to overcome them
Expert Opinion on Drug Discovery, Vol. 14, Núm. 10, pp. 957-968
-
Simultaneous depression of immunological synapse and endothelial injury is associated with organ dysfunction in community-acquired pneumonia
Journal of Clinical Medicine, Vol. 8, Núm. 9
2016
-
Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients
American Journal of Gastroenterology, Vol. 111, Núm. 10, pp. 1456-1465
2014
2013
-
Silencing of the Charcot-Marie-Tooth disease-associated gene GDAP1 induces abnormal mitochondrial distribution and affects Ca2+ homeostasis by reducing store-operated Ca2+ entry
Neurobiology of Disease, Vol. 55, pp. 140-151
-
Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles
PLoS ONE, Vol. 8, Núm. 2